You are viewing: Mexico Gastrointestinal Products Market analysis

The Mexico Gastrointestinal Products Market was valued at $35 Million in 2024 and projected to reach to $46.2 Million by 2029, representing a compound annual growth rate of 5.7%. Mexico's gastrointestinal products market is positioned for sustained growth through 2029, with a CAGR of 5.7% reflecting the country's developing healthcare infrastructure and rising disease burden.

Mexico Gastrointestinal Products Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Mexico Gastrointestinal Products Market Trends and Insights

  • Mexico's market expansion is driven by increasing prevalence of gastrointestinal disorders, rising healthcare awareness, and growing access to diagnostic and therapeutic solutions across urban and emerging rural regions.
  • The Mexican healthcare sector's modernization and expanding middle-class population are key factors supporting demand for gastrointestinal products. Mexico's gastrointestinal products market benefits from demographic shifts and lifestyle changes that elevate digestive health concerns among consumers.
  • Mexico's pharmaceutical and medical device sectors are increasingly investing in gastrointestinal solutions, supported by regulatory improvements and distribution network expansion.
  • Over the forecast period through 2029, Mexico is expected to maintain steady growth momentum as healthcare infrastructure development and patient education initiatives strengthen market penetration..

Key Market Statistics

  • CAGR (2024-2029) 5.7% CAGR
  • Market Size, 2024 ~USD 35 Million
  • Forecast, 2029 ~USD 46.2 Million
  • Country Mexico

Mexico Gastrointestinal Products Market Overview

Market Valuation Growth :

Mexico's gastrointestinal products market reached $35.0 million in 2024 and is expected to expand to $46.2 million by 2029, demonstrating steady market maturation and increasing demand for GI healthcare solutions.

Rising GI Disorder Prevalence :

Increasing prevalence of gastrointestinal disorders across Mexico's population is driving demand for diagnostic tools, therapeutic medications, and preventive solutions in both urban and rural healthcare settings.

Healthcare Awareness Expansion :

Growing healthcare awareness among Mexican consumers is leading to earlier diagnosis and treatment-seeking behavior, expanding the addressable market for gastrointestinal products and services.

Rural Market Penetration :

Improved access to diagnostic and therapeutic solutions in emerging rural areas of Mexico is unlocking new growth opportunities and broadening the customer base beyond traditional urban centers.

Mexico Gastrointestinal Products Market Dynamics

  • The market benefits from increasing healthcare accessibility in both metropolitan and rural regions, supported by growing consumer awareness of GI health issues and treatment options.
  • Pharmaceutical companies and medical device manufacturers are expanding their presence in Mexico to capitalize on this emerging opportunity. Key growth drivers include demographic shifts, lifestyle changes contributing to GI disorders, and improved reimbursement mechanisms.
  • As Mexico's middle class expands and healthcare spending increases, demand for both preventive and therapeutic gastrointestinal products will accelerate.
  • Strategic partnerships with local distributors and healthcare providers will be essential for companies seeking to capture market share in this dynamic Latin American market..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Mexico's gastrointestinal products market is valued at $35.0 million in 2024 and will reach $46.2 million by 2029.
    • Mexico's market is growing at a 5.7% CAGR, driven by rising gastrointestinal disorder prevalence and healthcare modernization.
    • Mexico's expanding middle class and improved healthcare access are primary growth catalysts for gastrointestinal product demand.
    • Mexico's pharmaceutical sector investment and regulatory improvements support sustained market expansion through 2029.

    Gastrointestinal Products Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment IRRITABLE BOWEL SYNDROME (IBS) (Disease)
    Forecast Period 2024-2029
    Growth Rate CAGR of 6.1% from 2024 to 2029
    Largest Segment ENDOSCOPY DEVICES (Device)
    Market Size Base Year (Billions) ~USD 14.65 (2024)
    Revenue Forecast (Billions) ~USD 19.7 (2029)
    Segments Covered Device, Type, Disease, End User

    Mexico Gastrointestinal Products Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Device

    • Ablation Devices
    • Biopsy Devices
    • Endoscopy Devices
    • Motility Testing Devices
    • Other Gastroenterology/ Gastrointestinal Devices
    • Other Gastroenterology/Gastrointestinal Devices
    • Ph Monitoring Devices
    • Stenting Devices

    By Type

    • 4-Hour Ph Impedance Testing Devices
    • Ambulatory Ph Monitoring Systems
    • Anorectal Manometry Devices
    • Biliary Stents
    • Capsule Endoscopes
    • Colonic Stents
    • Cryoablation Devices
    • Duodenal Stents
    • Esophageal Manometry Devices
    • Esophageal Ph Monitoring Catheters
    • Esophageal Stents
    • Flexible Endoscopes
    • Gastric Balloons
    • Gastrointestinal Tubes
    • Hemorrhoid Treatment Devices
    • Laser Ablation Devices
    • Microwave Ablation Devices
    • Needle Biopsy Devices
    • Other Ablation Devices
    • Other Biopsy Devices
    • Other Endoscopy Devices
    • Other Motility Testing Devices
    • Pancreatic Stents
    • Radiofrequency Ablation Devices
    • Rigid Endoscopes
    • Wireless Ph Monitoring Capsules

    By Disease

    • Gastroesophageal Reflux Disease (Gerd)
    • Gastrointestinal Cancers
    • Inflammatory Bowel Disease (Ibd)
    • Irritable Bowel Syndrome (Ibs)
    • Other Diseases

    By End User

    • Ambulatory Surgical Centers & Independent Diagnostic Centers
    • Clinics
    • Hospitals
    • Other End Users

    MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    AMBULATORY SURGICAL CENTERS & INDEPENDENT DIAGNOSTIC CENTERS18.819.420.221.121.922.923.827.66.4
    CLINICS8.58.78.899.29.49.610.94.4
    HOSPITALS24.82627.328.830.43233.830.82.4
    OTHER END USERS7.47.57.77.98.18.38.59.74.7
    TOTAL59.461.664.166.869.672.675.7794.3

    Target Audience

    • Pharmaceutical Companies : Pharmaceutical manufacturers need Mexico-specific market data to guide product development, pricing strategies, and go-to-market plans for gastrointestinal medications and therapeutic solutions in this growing Latin American market.
    • Medical Device Manufacturers : Device companies require detailed insights into Mexico's diagnostic and therapeutic equipment market to identify distribution opportunities, understand regulatory pathways, and assess demand for GI diagnostic tools and treatment devices.
    • Healthcare Investors : Investment firms and private equity groups need Mexico market analysis to evaluate acquisition targets, assess portfolio company growth potential, and identify emerging opportunities in the gastrointestinal healthcare sector.
    • Healthcare Distributors : Distributors and logistics providers need market intelligence to optimize supply chain strategies, forecast demand across Mexican regions, and identify high-potential product categories and customer segments.
    • Market Consultants : Consulting firms and business strategists require Mexico-specific GI market data to support client advisory services, competitive analysis, and strategic planning for healthcare organizations entering or expanding in the Mexican market.

    Reasons to Buy this Report

    • Market Entry Strategy : Gain comprehensive insights into Mexico's GI market dynamics to develop targeted market entry strategies, identify key distribution channels, and understand competitive positioning specific to Mexican healthcare regulations and consumer preferences.
    • Growth Opportunity Assessment : Evaluate the 5.7% CAGR opportunity with detailed market sizing and forecasts through 2029, enabling informed investment decisions and resource allocation for expansion into Mexico's gastrointestinal products sector.
    • Regional Expansion Planning : Understand urban versus rural market dynamics in Mexico to optimize product distribution strategies, identify underserved regions with highest growth potential, and tailor marketing approaches for different demographic segments.
    • Competitive Intelligence : Access Mexico-specific market analysis to benchmark against competitors, identify market gaps, and develop differentiated product offerings that address local healthcare needs and regulatory requirements.
    • Stakeholder Alignment : Provide board members, investors, and partners with credible Mexico market data to support business cases, justify capital investments, and align organizational strategy with Latin American growth opportunities in gastrointestinal healthcare.

    Frequently asked questions

    What is the current size of Mexico's gastrointestinal products market?

    Mexico's gastrointestinal products market was valued at $35.0 million in 2024.

    What is the projected market size for Mexico by 2029?

    Mexico's gastrointestinal products market is projected to reach $46.2 million by 2029.

    What is the CAGR for Mexico's gastrointestinal products market?

    Mexico's gastrointestinal products market is expected to grow at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2029.

    What are the main drivers of growth in Mexico's gastrointestinal products market?

    Key growth drivers in Mexico include increasing prevalence of gastrointestinal disorders, rising healthcare awareness, healthcare infrastructure modernization, and expansion of the middle-class population.

    How does Mexico's gastrointestinal market compare to other North American countries?

    Mexico's 5.7% CAGR reflects steady regional growth, with market expansion supported by demographic trends and healthcare sector development specific to Mexico's economic and healthcare landscape.

    RESEARCH METHODOLOGY

    The study involved four major activities to estimate the current size of the gastroenterology products market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of Gastrointestinal Products Market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    Extensive primary research was conducted after obtaining information regarding the Gastroenterology Products Market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the gastrointestinal products market.; and key opinion leaders.

    Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market. the following is a breakdown of the primary respondents:

    Gastroenterology Products Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The research methodology used to estimate the size of the gastrointestinal products market includes the following details. The market sizing of the market was undertaken from the global side.

    Country-Level Analysis

    The size of the gastrointestinal products market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall gastrointestinal products market was obtained from secondary data and validated by primary participants to arrive at the total gastroenterology products market. Primary participants further validated the numbers.

    Geographic Market Assessment (By Region & Country)

    • Approach 1:
      • Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends.
    • Approach 2:
      • Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews).

    At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Gastroenterology/Gastrointestinal Products Market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

    Global Gastrointestinal Products Market Size: Bottom-Up Approach

    Global Gastrointestinal Products Market Size: Bottom-Up Approach

    Global Gastrointestinal Products Market Size: Top-Down Approach

    Global Gastrointestinal Products Market Size: Top-Down Approach

    To know about the assumptions considered for the study, Request for Free Sample Report

    Data Triangulation

    After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the gastrointestinal products market.

    Market Definition

    Gastroenterology products encompass a variety of medical devices, diagnostic tools, and pharmaceuticals designed to diagnose, treat, and manage diseases and disorders of the gastrointestinal tract. These products include endoscopes, capsule endoscopy systems, ablation devices, stents, and specialized medications aimed at conditions like GERD, IBD, and colorectal cancer. Their purpose is to improve patient outcomes by offering advanced solutions for both diagnostic and therapeutic procedures within the GI tract.

    Key Stakeholders

    • Medical Device Manufacturers
    • Healthcare Institutions (hospitals and outpatient clinics)
    • Distributors and Suppliers
    • Research Institutes
    • Health Insurance Payers
    • Market Research and Consulting Firms

    Report Objectives

    • To define, describe, segment, and forecast the global gastrointestinal Products Market by devices, diseases end users, and region.
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall gastrointestinal products market.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
    • To forecast the size of the gastroenterology products market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile key players in the global gastrointestinal products market and comprehensively analyze their core competencies2 and market shares.
    • To track and analyze competitive developments such as acquisitions, expansions, partnerships, agreements, and collaborations; and product launches and approvals.
    • To benchmark players within the gastrointestinal products market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Product Analysis

    • Product matrix, which gives a detailed comparison of the product portfolios of each company

    Geographic Analysis

    • Further breakdown of the Latin American apheresis into specific countries and, the Middle East, and Africa apheresis into specific countries and further breakdown of the European apheresis into specific countries

    Get the Full Gastrointestinal Products Market Report

    Full forecast, segment splits, and company analysis for all Gastrointestinal Products Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status